Cartagenia is a Belgian startup founded in 2008, specializing in delivering diagnostic knowledge, software, and database systems focused on enabling genetic labs and clinicians to conduct clinically relevant genetic analyses efficiently. The company aims to facilitate high-quality genetic interpretation and counseling for patients and caregivers. Cartagenia secured a noteworthy €4.25M in its last venture round investment on 30 May 2014, with investors including KU Leuven Research & Development and Digital-Healthcare.
We care about your data, and we'd love to use cookies make your experience better.